患者操作远程皮肤镜:偏振与自然光皮肤镜的随机对照研究
该研究嵌套于MEL-SELF试验,比较低成本自然光非偏振与高成本偏振皮肤镜用于早期黑色素瘤治疗后患者自检的远程皮肤镜。251例随机分组,主要结局为基线图像质量可支持远程皮肤科医生建议的比例,两组差异无统计学意义(71.9% vs 67.5%),但偏振设备每张图像可报告率更高且成本更高。
要点
- 偏振与自然光皮肤镜的基线图像可支持建议比例无显著差异。
- 每张图像分析中偏振设备可报告率更高(95.0% vs 91.1%)。
- 自然光皮肤镜更常出现模糊和光照不足问题。
核心结论
- 两种设备均能使患者完成皮肤镜检查并获得远程皮肤科建议。
- 偏振设备的图像质量优势有限,需权衡其显著更高的成本。
研究设计与样本
- 随机对照研究嵌套于MEL-SELF试验,纳入251例既往接受早期黑色素瘤治疗(AJCC 0-II期)的成人,1:1随机分配至偏振(128例)或自然光(123例)皮肤镜智能手机附件。
主要发现
- 基线图像获得远程皮肤科医生管理建议的比例:偏振组92/128(71.9%),自然光组83/123(67.5%),差异4.4%(95%CI -7.0%至15.8%)。
- 12个月内至少获得1次建议的比例:偏振组104/128(81.3%),自然光组94/123(76.4%),差异4.3%(95%CI -8.1%至16.6%)。
- 每张图像可报告并支持建议的比例:偏振组913/961(95.0%),自然光组706/775(91.1%),差异3.9%(95%CI 1.5%至6.3%);自检病变差异6.8%(95%CI 3.3%至10.2%)。
- 自然光图像更常出现模糊(14 vs 9)和光照不足(6 vs 0),远程皮肤科医生对偏振图像给予更多正面反馈。
- 患者可用性评分相似(中等/非常容易:39.8% vs 36.6%,差异3.2%,95%CI -8.8%至15.3%),但自然光设备用户报告更多图像质量问题。
临床怎么用
- 在患者自检远程皮肤镜中,自然光皮肤镜可作为低成本选择,但需注意图像模糊和光照不足问题。
- 偏振设备可提高每张图像的可报告率,但成本显著更高,选择时需权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patient-performed teledermoscopy may improve access to dermatologic care, but evidence to guide dermatoscope selection for patient use is limited. OBJECTIVE: To compare a lower-cost, ambient-light, nonpolarized dermatoscope with a higher-cost, illuminated, polarized dermatoscope for patient-performed teledermoscopy following treatment for early-stage melanoma. DESIGN, SETTING, AND PARTICIPANTS: This randomized study within a trial was embedded within the MEL-SELF trial and recruited adults previously treated for early-stage melanoma (American Joint Committee on Cancer stages 0-II) in the patient-led surveillance arm of MEL-SELF from specialist and general practitioner-led skin cancer clinics in Australia from December 2021 to June 2024 with 12-month follow-up. Data were analyzed from February 6, 2025, to August 15, 2025. INTERVENTIONS: Participants were randomized (1:1) to receive a polarized (128 [51.0%]) or ambient-light (123 [49.0%]) dermatoscope smartphone attachment. Optional online training was provided. Participants submitted clinician-identified and self-detected lesion images via a secure teledermatology platform at 3-month intervals. MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion of participants submitting baseline images of sufficient quality for a teledermatologist to provide a management recommendation. Secondary outcomes included the proportion receiving a management recommendation for at least 1 image during the study period, per-image recommendation proportions, device costs, and qualitative assessments of image quality and usability. RESULTS: Of 251 participants (mean [SD] age, 56.0 [11.6] years; 147 female individuals [59%]), 175 (69.7%) received a teledermatologist management recommendation for baseline images (polarized: 92 [71.9%]; ambient light: 83 [67.5%]; difference, 4.4%; 95% CI, -7.0% to 15.8%). By 12 months, the proportion receiving at least 1 recommendation was similar between groups (polarized: 104 of 128 [81.3%]; ambient light: 94 of 123 [76.4%]; difference, 4.3%; 95% CI, -8.1% to 16.6%). However, a per-image analysis showed more polarized images (913 of 961 [95.0%]) than ambient-light images (706 of 775 [91.1%]) were reportable and supported a recommendation (difference, 3.9%; 95% CI, 1.5% to 6.3%; self-directed lesions: 6.8%; 95% CI, 3.3% to 10.2%). Teledermatologists provided more positive feedback for polarized images; blurriness (n = 14 vs 9) and poor lighting (n = 6 vs 0) were more frequent with ambient-light images. Patient usability ratings were similar (moderately/very easy: 39.8% vs 36.6%; difference, 3.2%; 95% CI, -8.8% to 15.3%), but ambient-light dermatoscope users reported more image quality issues. The polarized device was more expensive ($324.16 vs $35.40). CONCLUSIONS AND RELEVANCE: The results of this study within a trial indicate that both devices enabled patients to perform dermoscopy and receive teledermatology recommendations. The modest image quality advantages of the polarized device must be weighed against its substantially higher cost. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12621000176864.
引用
- Ackermann DM, Medcalf E, Turner RM, et al. Mobile Dermatoscope Type in Patient-Performed Teledermoscopy: A Study Within A Trial. JAMA Dermatol. 2026. PMID: 41335403. doi:10.1001/jamadermatol.2025.4792
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。